reviewThe Lancet OncologyDec 1, 2017Closed access

De-novo and acquired resistance to immune checkpoint targeting

National University of Singapore · National University Cancer Institute, Singapore · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

729
total citations
FWCI
34.14
Percentile
100%
References
114
Citations per year

Authors

4

Topics & keywords

Keywords
  • Immunosurveillance
  • Biology
  • Immune system
  • Immune checkpoint
  • Immunotherapy
  • Programmed cell death
  • Cytotoxic T cell
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding